CWM
PBE icon

Cornerstone Wealth Management’s Invesco Biotechnology & Genome ETF PBE Stock Holding History

Cornerstone Wealth Management’s Portfolio PBE Stock Details PBE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-19,571
Closed -$353K – 1462
2018
Q2 		$353K Buy
+19,571
New +$995K ﹤0.01% 1126

Other funds holding PBE

ACM
Arlington Capital Management Arlington Heights, Illinois $161M AUM 38.38% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
LTFS
Ladenburg Thalmann Financial Services Miami, Florida $15.9B AUM 25.16% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
CAS
Cue Advisory Services Phoenix, Arizona $167M AUM 18.62% 1-Year Est. Return
AFM
Abbot Financial Management Andover, Massachusetts $239M AUM 27.19% 1-Year Est. Return

Cornerstone Wealth Management's PBE Position: Q3 2018 in Review

Cornerstone Wealth Management sold out of Invesco Biotechnology & Genome ETF (PBE) in Q3 2018, closing a stake of 19,571 shares — an estimated $353K sold.

Cornerstone Wealth Management first reported a position in PBE in Q2 2018 and held it in 1 quarter. The position peaked at $353K in Q2 2018. 74 funds tracked by Wall St. Rank hold PBE as of Q3 2018.

  • Cornerstone Wealth Management reported no remaining Invesco Biotechnology & Genome ETF position as of Q3 2018 after selling out during the quarter.
  • Cornerstone Wealth Management sold 19,571 Invesco Biotechnology & Genome ETF shares in Q3 2018, an estimated $353K.
  • Cornerstone Wealth Management first reported a position in Invesco Biotechnology & Genome ETF in Q2 2018 and held it in 1 quarter.
  • Cornerstone Wealth Management's Invesco Biotechnology & Genome ETF position peaked at $353K in Q2 2018.
  • 74 funds tracked by Wall St. Rank held Invesco Biotechnology & Genome ETF as of Q3 2018.

Based on Cornerstone Wealth Management's 13F filing for Q3 2018, filed 19 Oct 2018.